ProShares Ultra Nasdaq Biotechnology BIB | NASDAQ

BIB last paid $0.0413 a share on Sep 29, and returned 42.2% over 12 months with distributions counted. · 1-year total return +42.2% · Track BIB in a free portfolio

Dividends

Company Overview:

Market Cap: $70.72M
Trailing PE: N/A
FWD PE: —
Payout Ratio (TTM): —
52-Week Range: $36.89 - $63.20

10 Year BIB Performance Metrics:

Total Return (with DRIP): 133.9% (8.87% CAGR)
Total Return (no DRIP): 130.8% (8.73% CAGR)
Share Price: 127.3% (8.56% CAGR)
Yield on Cost (with DRIP): 0.73%
Total Invested: $10,000
Total Value (with DRIP): $23,389
Total Return $ (with DRIP): $13,389
Dividend Increase: 115.0% (22.63% CAGR)
Dividend Yield (FWD): 0.31% ($0.17)
BIB 10-yr Total Return ($10K invested)
1M 3M 6M YTD 1Y 3Y 5Y 10Y
BIB Share Price
1M 3M 6M YTD 1Y 3Y 5Y 10Y All
BIB Price CAGR:1Y: 41.93%2Y: 39.97%5Y: 4.54%10Y: 8.56%

BIB Dividend Payments & Yield

Dividend Payments & Yield
BIB Dividend CAGR:1Y: -51.60%2Y: -44.16%5Y: 13.43%10Y: 13.43%
Annual Dividends (Total Paid Per Year)
Dividend Growth Year Over Year

Compare stocks side-by-side

BIB Dividends Info:

Annual Dividend: $0.165108
Forward Yield: 0.31%
Ex-Dividend Date: 2026-09-23
Lifetime Dividends / Share: $0.81

Projected Future Returns & Dividends for BIB

Based on past 10-year performance, here are BIB growth metrics:

Share price CAGR of +8.56%
Dividend CAGR of +22.35%

Using BIB CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

BIB (DRIP)BIB - No DRIP
Current Price$53.21$53.21
Start Shares187.93187.93
Start Value$10,000$10,000
  
After 10 years:
Final Share Count198.82187.93
Dividends Payment$0.31$0.31
Annual Dividends$247$233
Yield on cost2.47%2.33%
Share Price$120.94$120.94
Total Dividends$933$905
Final Value$24,046$23,635

Estimated Future Value + Dividends - BIB

NOTE: Above numbers are our estimate based on BIB's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Company Info

ProShares Ultra Nasdaq Biotechnology (BIB) had its IPO on 2010-04-07, and is traded on NASDAQ stock exchange.

ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.

BIB website: https://www.proshares.com/funds/bib.html


Loading signals…

DCF model unavailable for BIB — no fundamentals on file (ETFs and funds are not modelable).